Skip to main content

Knowledge Zone

Brief summaries of the market access landscape for medical technologies and in-vitro diagnostic tests in European countries

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

A new framework agreement on the medical devices included in the LPPR was signed in France

On July 11, 2024, the Ministry of Labor, Health and Solidarity announced that the Economic Committee for Health Products (CEPS) and several organizations representing manufacturers (Snitem, UFAT, Entreprises de la Nutrition Clinique, and AFIDEO) signed a new framework agreement relating to the conventional policy for setting and revising the prices of products included in the list of products and services (LPPR) on July 2, 2024.

This framework agreement governs the relations between the CEPS and the members of the signatory professional organizations, specifically operators, manufacturers, or distributors. It aims to give economic actors visibility and facilitate tariff negotiations.

The framework agreement establishes a Conventional Policy Monitoring Committee (CSPC). Its purpose is to address any subject contributing to developing the conventional policy for products and services listed in the LPPR. The CSPC will meet at least twice a year, with the first meeting in September 2024.

This agreement is applicable for three years after the parties' signature.

More details in French can be found here

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.